Please use this identifier to cite or link to this item: https://doi.org/10.1080/21645515.2020.1861875
Title: Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized Phase II, placebo-controlled trial
Authors: Eujung Juliana Park
SOPHIA ARCHULETA 
May-Lin Helen Oh
LYNETTE PEI-CHI SHEK 
Hao Wang
Matthew Bonaparte
Carina Frago
Alain Bouckenooghe
Frederique Jantet-Blaudez
Sarah Begue
Sophie Gimenez-Fourage
Anke Pagnon
Issue Date: 24-Feb-2021
Publisher: Taylor & Francis
Citation: Eujung Juliana Park, SOPHIA ARCHULETA, May-Lin Helen Oh, LYNETTE PEI-CHI SHEK, Hao Wang, Matthew Bonaparte, Carina Frago, Alain Bouckenooghe, Frederique Jantet-Blaudez, Sarah Begue, Sophie Gimenez-Fourage, Anke Pagnon (2021-02-24). Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized Phase II, placebo-controlled trial. Human Vaccines & Immunotherapeutics 17 (7) : 2107-2116. ScholarBank@NUS Repository. https://doi.org/10.1080/21645515.2020.1861875
Source Title: Human Vaccines & Immunotherapeutics
URI: https://scholarbank.nus.edu.sg/handle/10635/194505
ISSN: 21645515
DOI: 10.1080/21645515.2020.1861875
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10.108021645515.2020.1861875.zip3.88 MBZIP

OPEN

PublishedView/Download

Page view(s)

85
checked on May 12, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.